- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mayinglong Pharmaceutical Group Co Ltd (600993)
Mayinglong Pharmaceutical Group Co Ltd stock price live, this page displays SS 600993 stock exchange data. View the 600993 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mayinglong Pharmaceutical Group Co Ltd real time stock price chart below.
What Is the Mayinglong Pharmaceutical Group Co Ltd Stock Price Today?
The Mayinglong Pharmaceutical Group Co Ltd stock price today is 28.03.
What Is the Stock Symbol for Mayinglong Pharmaceutical Group Co Ltd?
The stock symbol for Mayinglong Pharmaceutical Group Co Ltd is "600993."
What Stock Exchange Does Mayinglong Pharmaceutical Group Co Ltd Trade On?
Mayinglong Pharmaceutical Group Co Ltd is listed and trades on the Shanghai stock exchange.
Is Mayinglong Pharmaceutical Group Co Ltd a Good Stock to Buy?
Determining whether Mayinglong Pharmaceutical Group Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600993 quote. (ISIN: CNE000001HN2)
What Is the Mayinglong Pharmaceutical Group Co Ltd Stock Price Today?
The Mayinglong Pharmaceutical Group Co Ltd stock price today is 28.03.
What Is the Stock Symbol for Mayinglong Pharmaceutical Group Co Ltd?
The stock symbol for Mayinglong Pharmaceutical Group Co Ltd is "600993."
What Stock Exchange Does Mayinglong Pharmaceutical Group Co Ltd Trade On?
Mayinglong Pharmaceutical Group Co Ltd is listed and trades on the Shanghai stock exchange.
Is Mayinglong Pharmaceutical Group Co Ltd a Good Stock to Buy?
Determining whether Mayinglong Pharmaceutical Group Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600993 quote. (ISIN: CNE000001HN2)
Shanghai
Currency in CNY
28.03
-0.45(-1.58%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.98
28.54
52 wk Range
23.42
31.46
600993 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.9828.54
52 wk Range
23.4231.46
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600993 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
35.75
Upside
+27.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Mayinglong Pharmaceutical Group Co Ltd Company Profile
Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as well as automobile freight services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; provision of hospital and medical management service; and hospital operations. Further, it imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.
Compare 600993 to Peers and Sector
Metrics to compare | 600993 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600993PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.1x | 21.1x | −0.6x | |
PEG Ratio | 1.13 | 0.83 | 0.00 | |
Price/Book | 2.8x | 2.2x | 2.6x | |
Price / LTM Sales | 3.2x | 3.3x | 3.3x | |
Upside (Analyst Target) | 27.5% | 28.1% | 39.8% | |
Fair Value Upside | Unlock | 15.8% | 4.3% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 35.75
(+27.54% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
0.36 / --
Revenue / Forecast
888.00M / --
People Also Watch
FAQ
What Is the Mayinglong Pharm (600993) Stock Price Today?
The Mayinglong Pharm stock price today is 28.03
What Stock Exchange Does Mayinglong Pharm Trade On?
Mayinglong Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Mayinglong Pharm?
The stock symbol for Mayinglong Pharm is "600993."
Does Mayinglong Pharm Pay Dividends? What’s The Current Dividend Yield?
The Mayinglong Pharm dividend yield is 2.21%.
What Is the Mayinglong Pharm Market Cap?
As of today, Mayinglong Pharm market cap is 12.08B.
What Is Mayinglong Pharm's Earnings Per Share (TTM)?
The Mayinglong Pharm EPS (TTM) is 1.33.
When Is the Next Mayinglong Pharm Earnings Date?
Mayinglong Pharm will release its next earnings report on Oct 30, 2025.
From a Technical Analysis Perspective, Is 600993 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Mayinglong Pharm Stock Split?
Mayinglong Pharm has split 6 times.
How Many Employees Does Mayinglong Pharm Have?
Mayinglong Pharm has 2654 employees.
What is the current trading status of Mayinglong Pharm (600993)?
As of Jan 07, 2026, Mayinglong Pharm (600993) is trading at a price of 28.03, with a previous close of 28.48. The stock has fluctuated within a day range of 27.98 to 28.54, while its 52-week range spans from 23.42 to 31.46.
What Is Mayinglong Pharm (600993) Price Target According to Analysts?
The average 12-month price target for Mayinglong Pharm is CNY35.75, with a high estimate of CNY38.5 and a low estimate of CNY33. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.54% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.